다른 언어로 보기
Regeneus Ltd
ASX:RGS ISIN:AU000000RGS6
Regeneus Ltd (ASX:RGS) is a Sydney-based clinical-stage regenerative medicine company using stem cell technologies to develop a portfolio of novel cell-based therapies. The regenerative therapies seek to address unmet medical needs in human health markets, focusing on neuropathic pain, including osteoarthritis and various skin conditions, with its platform technologies Progenza(TM) and Sygenus. Visit www.regeneus.com.au for more information.
뉴스
###
163,680 회사 소개
- 검색 횟수: (지난 7일간: 58) (지난 30일간: 211) (게재 이후: 18719)
